Filing Details
- Accession Number:
- 0001567619-23-005055
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-14 17:00:28
- Reporting Period:
- 2023-03-10
- Accepted Time:
- 2023-03-14 17:00:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1080014 | Innoviva Inc. | INVA | Pharmaceutical Preparations (2834) | 943265960 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1813426 | Pavel Raifeld | 1350 Old Bayshore Highway, Suite 400 Burlingame CA 94010 | Chief Executive Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-03-10 | 3,000 | $10.87 | 9,799 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions in the open market at prices ranging from $10.865 to $10.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 1 to this Form 4.
- Includes (1) 2,266 shares of common stock acquired under the Innoviva, Inc. Employee Stock Purchase Plan on May 13, 2022, and (2) 3,000 shares of common stock acquired in multiple transactions in the open market on March 10, 2023, as described in greater detail in footnote 1 to this Form 4.